SCHEMBL16628432

SCHEMBL16628432

CCCCCNC(CCO)CCCC

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NAAA Q02083 1/20 0.37
LMNA P02545 5/20 0.37
ALDH1A1 P00352 4/20 0.37
TSHR P16473 2/20 0.37
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TLR8 Q9NR97 1/20 0.37
TLR7 Q9NYK1 1/20 0.37
KDM4E B2RXH2 2/20 0.37
CNR1 P21554 1/20 0.37
ADRA1A P35348 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ABCC3 O15438 1/20 0.35
KCNH2 Q12809 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12521850 0.96 SMN1; SMN2 (0.42) EPHX1DPP7SMN1; SMN2NAAALMNA
SCHEMBL3124267 0.94 LMNA (0.44) EPHX1SMN1; SMN2NAAALMNAALDH1A1
SCHEMBL2567393 0.94 LMNA (0.44) EPHX1SMN1; SMN2NAAALMNAALDH1A1
Hydrochloric Acid SCHEMBL5353822 0.92 LMNA (0.42) EPHX1SMN1; SMN2NAAALMNAALDH1A1
Hydrochloric Acid SCHEMBL1804687 0.92 LMNA (0.42) EPHX1SMN1; SMN2NAAALMNAALDH1A1
Bromide SCHEMBL10985393 0.92 LMNA (0.42) EPHX1SMN1; SMN2NAAALMNAALDH1A1
SCHEMBL9948939 0.89 SMN1; SMN2 (0.46) EPHX1DPP7SMN1; SMN2NAAALMNA
SCHEMBL11897245 0.89 EPHX1 (0.48) EPHX1DPP7ALDH1A1TSHR
SCHEMBL17997993 0.88 LMNA (0.40) EPHX1SMN1; SMN2LMNAALDH1A1TSHR
SCHEMBL9949550 0.87 ALDH1A1 (0.43) DPP7SMN1; SMN2LMNAALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2860170-B1 PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE OSAKA ORGANIC CHEMICAL IND LTD (JP) 2019-08-28 EP disclosed
EP-3015449-B1 (METH)ACRYLATE PRODUCTION SYSTEM OSAKA ORGANIC CHEMICAL IND LTD (JP) 2018-10-10 EP disclosed
US-9670129-B2 Process for preparing 4-hydroxybutyl acrylate OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) 2017-06-06 US disclosed
US-20160136538-A1 (METH)ACRYLATE PRODUCTION SYSTEM OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) 2016-05-19 US disclosed
EP-3015449-A1 (METH)ACRYLATE PRODUCTION SYSTEM Osaka Organic Chemical Ind., Ltd. (JP) 2016-05-04 EP disclosed
US-20150126766-A1 PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) 2015-05-07 US disclosed
EP-2860170-A1 PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE Osaka Organic Chemical Ind., Ltd. (JP) 2015-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150126766-A1 PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE LTB4R2, LTA4H, LTB4R EPHX1 518/4885DPP7 1640/4885SMN1; SMN2 4680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.